Skip to main content
Premium Trial:

Request an Annual Quote

NIH Extends Agreement with Galapagos for MLSMR

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Galapagos announced today that the National Institutes of Health have extended the service agreement with BioFocus to operate the Molecular Libraries Small Molecule Repository through December 2012.

As a result of the contract, Galapagos could receive up to $8.6 million during the course of the extension.

BioFocus is Galapagos' service division and helps its partners to accelerate the gene-to-drug candidate discovery process. It runs a compound management facility for a number of industrial and US government customers out of Compound Focus, a subsidiary based in South San Francisco, Calif.

BioFocus has been the home to MLSMR since 2004, and under its NIH contract acquires and stores compounds and distributes them for high-throughput biological screening throughout NIH's network in the US.

MLSMR is a component of the Molecular Libraries Initiative, an NIH Roadmap project.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.